Patterns of drug therapy, glycemic control, and predictors of escalation – non-escalation of treatment among diabetes outpatients at a tertiary care center
Author:
Atal Shubham1, Joshi Rajnish2, Misra Saurav1ORCID, Fatima Zeenat1, Sharma Swati1, Balakrishnan Sadashivam1, Singh Pooja3
Affiliation:
1. Department of Pharmacology , AIIMS Bhopal , Bhopal , India 2. Department of General Medicine , AIIMS Bhopal , Bhopal , India 3. Department of Pharmacology , R.N.T. Medical College , Udaipur , India
Abstract
Abstract
Objectives
The study was conducted to assess patterns of prescribed drug therapy and clinical predictors of need for therapy escalation in outpatients with diabetes mellitus (DM).
Methods
This was a prospective cohort study, conducted at an apex tertiary care teaching hospital in central India for a period of 18 months. The demographic, clinical, and treatment details on the baseline and follow up visits were collected from the patients’ prescription charts. Glycemic control, adherence, pill burdens along with pattern of antidiabetic therapy escalation, and deescalations were analyzed.
Results
A total of 1,711 prescriptions of 925 patients of diabetes with a mean age of 53.81 ± 10.42 years and duration of disease of 9.15 ± 6.3 years were analyzed. Approximately half of the patients (n=450) came for ≥1 follow up visits. Hypertension (59.35%) was the most common comorbidity followed by dyslipidemia and hypothyroidism. The mean total daily drugs and pills per prescription were 4.03 ± 1.71 and 4.17 ± 1.38, respectively. Metformin (30.42%) followed by sulphonylureas (SUs) (21.39%) constituted majority of the AHA’s and dual and triple drug therapy regimens were most commonly prescribed. There were improvements in HbA1c, fasting/postprandial/random blood sugar (FBS/PPBS/RBS) as well as adherence to medication, diet, and exercise in the follow up visits. Among patients with follow ups, therapy escalations were found in 31.11% patients, among whom dose was increased in 12.44% and drug was added in 17.28%. Apart from Hb1Ac, FBS, and PPBS levels (p<0.001), characteristics such as age, BMI, duration of diagnosed diabetes, presence of hypertension and dyslipidemia, and daily pill burdens were found to be significantly higher in the therapy escalation group (p<0.05). Inadequate medication adherence increased the relative risk (RR) of therapy escalation by almost two times.
Conclusions
Disease and therapy patterns are reflective of diabetes care as expected at a tertiary care center. Higher BMI, age, pill burden, duration of diabetes, presence of comorbidities, and poor medication adherence may be the predictors of therapy escalation independent of glycemic control and such patients should be more closely monitored.
Publisher
Walter de Gruyter GmbH
Subject
Drug Discovery,Pharmacology,General Medicine,Physiology
Reference50 articles.
1. IDF diabetes Atlas 9th edition 2019. Available from: https://www.diabetesatlas.org/en/ [Accessed 5 Jun 2021]. 2. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999. 3. Diabetes a major health challenge for India [Internet]. Available from: https://www.cnbctv18.com/views/diabetes-a-major-health-challenge-for-india-8330931.htm [Accessed 20 Apr 2021]. 4. Anjana, RM, Deepa, M, Pradeepa, R, Mahanta, J, Narain, K, Das, HK, et al.. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol 2017;5:585–96. https://doi.org/10.1016/s2213-8587(17)30174-2. 5. Sosale, A, Prasanna Kumar, KM, Sadikot, SM, Nigam, A, Bajaj, S, Zargar, AH, et al.. Chronic complications in newly diagnosed patients with type 2 diabetes mellitus in India. Indian J Endocrinol Metab 2014;18:355–60. https://doi.org/10.4103/2230-8210.131184.
|
|